• National Cancer Institute
  • National Human Genome Research Institute

TCGA In The NewsRSS

The Cancer Genome Atlas (TCGA) Research Network is providing data and genome analysis to the cancer research community which is supporting new discoveries and accelerating the pace of cancer research. Below is a list of selected articles that describe the broad impact of TCGA on cancer research.


  • March 02, 2012
    Combing the Cancer Genome
    The Scientist gives a guided tour through the main online resources for analyzing data from The Cancer Genome Atlas. The article discusses tools available within the TCGA Data Portal, and outside it.
  • December 23, 2011
    TCGA Considered a "Notable Advance"
    The Cancer Genome Atlas is considered a "Notable Advance" according to a report compiled by 18 prominent oncologists, covering the period from October 2010 to September 2011. "Notable Advances" are research that has had a significant impact on the way a cancer is understood or has had a direct impact on patient care.
  • August 16, 2011
    TCGA Ranks in Top Five of Most Highly Ranked Articles
    In this snapshot of the most highly ranked articles in molecular biology, The Cancer Genome Atlas Research Network's article “Integrated genomic analyses of ovarian carcinoma”, published in Nature, is number five.
  • July 30, 2011
    Cancer-Gene Analysis Customizes Treatment
    Dr. Douglas Levine, a physician and researcher at Memorial Sloan-Kettering Cancer Center, discusses the impact of understanding cancer genetics as it relates to a patient's care.
  • November 30, 2010
    Audio: Researchers Discover Key Mutation in Acute Myeloid Leukemia
    Tim Ley, M.D., Washington University researcher, discusses the importance of a key mutation found in acute myeloid leukemia. This mutation may be an important tool to classify patients for treatment.
  • November 12, 2010
    Mutations in Single Gene Predict Poor Outcomes in Adult Leukemia
    Washington University School of Medicine researchers discover a gene found to be commonly altered in many patients who died quickly of the disease.
  • August 11, 2010
    Francis Collins: One Year at the Helm
    Francis Collins, Ph.D., marks his one-year anniversary as the National Institutes of Health (NIH) director. This Nature article addresses his accomplishments to date, including his investment in TCGA, and the challenges he faces ahead.
  • August 01, 2010
    Fostering Groundbreaking Medical Research: Investments in the National Institutes of Health
    The White House reports on how Recovery Act funds are enabling groundbreaking research at NIH, including genomic mapping of 20 cancers through the TCGA project.
  • April 06, 2010
    House Committee Convenes Hearing on NCI Research
    Former NCI Deputy Director Dr. Anna Barker testified before the House of Representatives Committee on Energy and Commerce, Subcommittee on Health at a hearing held on March 23. Focusing on progress in molecular biology and advanced technologies, Dr. Barker provided an overview of TCGA emphasizing that the biggest challenge to expanding TCGA is obtaining high-quality biospecimens.
  • February 09, 2010
    Cancer Bulletin Profile: Meet Dr. Raju Kucherlapati
    The Cancer Bulletin profiles Raju Kucherlapati, Ph.D., a Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School, and a principal investigator for TCGA. Dr. Kucherlapati is working toward characterizing the genetic and genomic changes found in cancer samples with the goal of understanding how cancer develops and to identify meaningful subtypes of cancer in order to determine which drugs are most likely to work.
< Previous 1 2 3 4 Next >